+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

ASTRO-BCRF Emerging Investigator Award

American Society for Radiation Oncology

The Breast Cancer Research Foundation (BCRF) and ASTRO collaborate to offer a joint Emerging Investigator Award. The goal of this program is to foster and develop talented early career breast radiation oncology researchers. Multiple PIs and indirect costs are not allowed. For this joint award, the applicant must be a radiation oncologist, radiation or cancer biologist, or radiation physicist.

Deadline: January 12, 2026
Award Amount: $100,000 over one year

AI Based Application Success Predictor

1. Strong Alignment with Radiation Oncology

Projects must clearly integrate radiation therapy, radiation biology, radiation physics, radiobiology, translational oncology, or quality-improvement in radiation oncology. ASTRO states its “Funding Opportunities” page supports “bench to bedside” radiation research. Astro+1

Additionally, ASTRO’s FAQ states that applicants already funded by another grant may still apply if there is no overlap. Astro
Predictor: Your proposal must be clearly grounded in radiation oncology and show how it advances the field.

2. Appropriate Fit with the Grant Mechanism & Career Stage

ASTRO offers different opportunities: research grants, fellowships, pilot studies, early-career investigator awards, institutional grants (e.g., SCAROP* data indicates institutional performance matters) ResearchGate+1

Ensuring your career stage (postdoc, faculty, clinician-scientist) matches the specific mechanism is critical.
Predictor: Submit to the mechanism aligned with your experience, role and project scope.

3. Solid Preliminary Data / Feasibility

In radiation oncology research funding, feasibility is key: the review community will expect that the methods and model systems work, pilot results exist, or you have a credible path from bench to clinic. The institutional performance data in an ASTRO portfolio analysis suggest success tracks with robust institutional support and prior productivity. ResearchGate
Predictor: Having pilot data, or a convincing proof-of-concept, strengthens the application.

4. Robust Mentorship & Research Environment (Especially for Early Career Awards)

Early career/clinician scientists applying to ASTRO should demonstrate mentorship, access to radiation oncology research infrastructure (e.g., treatment planning systems, imaging, translational lab, dosimetry expertise).
Predictor: Applications showing strong institutional support, protected time, and a mentoring team tend to succeed.

5. Clear, Focused Specific Aims with Milestones

Successful proposals articulate 2-3 specific aims, with clear hypotheses, defined endpoints, timelines, and resource/method descriptions.

ASTRO emphasises clarity in its funding opportunities page. Astro
Predictor: A well-structured, feasible research plan with milestones supports higher reviewer confidence.

6. Innovation + Impact in Radiation Oncology

Projects that propose novel approaches (e.g., novel radiation sensitizers, radiobiology mechanisms, image-guided radiation therapy alterations, big data/AI for radiation planning/outcomes, or quality improvement in radiation clinical practice) are more competitive.
Predictor: Demonstrating how the work could change clinical practice or understanding in radiation oncology enhances competitiveness.

7. Demonstrated Track Record & Future Potential

Although early career applicants may have limited track record, showing productivity, relevant publications, and potential for future external funding (NIH, NCI, major foundations) helps. The institutional analysis in ASTRO’s portfolio suggests that institutions with stronger prior success may have higher funding rates. ResearchGate
Predictor: Evidence of productivity and a credible trajectory in radiation oncology research matters.

8. Engagement with the Radiation Oncology Community & ASTRO

While less directly stated, applicants who present at ASTRO annual meetings, engage with ASTRO committees, or publish in radiation oncology journals often are better recognised.
Predictor: Active involvement in the radiation oncology research community enhances credibility.

9. Clear Budget, Scope and No Overlap

ASTRO FAQ states: Applicants already funded can apply if there is no overlap in science or budget. Astro

Ensuring the budget reflects only the requested period and is realistic for the work proposed helps.
Predictor: Transparent, non-duplicative budget and realistic scope increase chance of success.

✅ Summary Table

Success Predictor	Why It Matters in ASTRO Funding
Radiation oncology‐specific focus	Aligns with ASTRO mission and reviewers’ expectations
Matching mechanism to applicant stage	Ensures reviewer expectations are aligned
Preliminary data / feasibility	Reduces risk in execution
Strong mentorship & environment	Provides infrastructure for success
Clear aims, milestones	Demonstrates plan is manageable
Innovation + clinical/translational impact	High value in radiation oncology research
Track record & future potential	Indicates investigator can deliver and sustain research
Community/ASTRO engagement	Signals supported by the field
Realistic budget, no overlap	Avoids conflict with ASTRO policy and enhances clarity

Specialties

Radiation Oncology

Eligibility Requirements

The applicant must be a radiation oncologist, radiation or cancer biologist, or radiation physicist.

Sponsor Details

Sponsor Institute/Organizations: American Society for Radiation Oncology

Sponsor Type: Corporate/Non-Profit

Address: 251 18th Street South, 8th Floor Arlington, VA 22202

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity